Skip header and navigation

Refine By

135 records – page 1 of 14.

[2 strategies in case of meningitis in Sweden]

https://arctichealth.org/en/permalink/ahliterature12246
Source
Nord Med. 1990;105(10):261, 265
Publication Type
Article
Date
1990
Author
A. Lindberg
Author Affiliation
Infektionskliniken, Länssjukhuset, Halmstad.
Source
Nord Med. 1990;105(10):261, 265
Date
1990
Language
Swedish
Publication Type
Article
Keywords
Adolescent
Adult
Ampicillin - therapeutic use
Anti-Bacterial Agents - therapeutic use
Bacterial Infections - drug therapy
Cephalosporins - therapeutic use
Child
Child, Preschool
Chloramphenicol - therapeutic use
English Abstract
Humans
Infant
Meningitis - drug therapy - microbiology
Abstract
In contrast to the other Nordic countries Sweden has long had a favourable position as regards meningococcal disease. In the last 10 year period the annual incidence has been only about one case per 100,000 inhabitants. The treatment once the cause is confirmed is conventional and no different from that in the other Nordic countries but varies somewhat in the event of unknown etiology. Cortisone therapy also seems to be more frequent in treatment of meningitis. Two strategies for antibiotic prophylaxis are used in Sweden.
PubMed ID
2235471 View in PubMed
Less detail

[44 cases of Hemophilus influenzae in the Laval University Hospital Center (1975-1979)].

https://arctichealth.org/en/permalink/ahliterature244381
Source
Union Med Can. 1981 Jul;110(7):611-6
Publication Type
Article
Date
Jul-1981

Aeromonas spp. isolated from ready-to-eat seafood on the Norwegian market: prevalence, putative virulence factors and antimicrobial resistance.

https://arctichealth.org/en/permalink/ahliterature312214
Source
J Appl Microbiol. 2021 Apr; 130(4):1380-1393
Publication Type
Journal Article
Date
Apr-2021
Author
H-J Lee
S Hoel
B-T Lunestad
J Lerfall
A N Jakobsen
Author Affiliation
Department of Biotechnology and Food Science, Norwegian University of Science and Technology, Trondheim, Norway.
Source
J Appl Microbiol. 2021 Apr; 130(4):1380-1393
Date
Apr-2021
Language
English
Publication Type
Journal Article
Keywords
Aeromonas - classification - drug effects - genetics - isolation & purification
Ampicillin - pharmacology
Animals
Anti-Bacterial Agents - pharmacology
Bacterial Proteins - genetics - metabolism
Drug Resistance, Bacterial
Food contamination - analysis
Norway
Prevalence
Seafood - microbiology
Virulence Factors - genetics - metabolism
Abstract
We aim to investigate the prevalence, putative virulence factors and antimicrobial resistance of mesophilic Aeromonas isolated from ready-to-eat (RTE) seafood available on the Norwegian market, and to assess the potential risks by consuming RTE seafood to consumers.
The prevalence of mesophilic Aeromonas in 148 RTE seafood was investigated and the highest prevalence was found in retail sushi (17%), followed by oysters (10%), fresh salmon loins (10%) and scallops (4%). Among 43 Aeromonas isolates, 75% of them were identified as A. media, 23% as A. salmonicida and 2% as A. bestiarum based on partial gryB gene sequencing. Aeromonas isolates were potentially pathogenic due to the presence of four virulence genes: alt (73%), hylA (22%), aerA (17%) and act (6%). In addition, all isolates were resistant to ampicillin and erythromycin. Most of the isolates (98%) were multidrug resistant.
The occurrence of potentially pathogenic and multidrug-resistant Aeromonas strains in RTE seafood implies a potential risk to consumers. Our finding suggests that RTE seafood could be a potential vehicle for the transfer of virulent and multidrug-resistant Aeromonas.
To our knowledge, this is the first study to report multiple antibiotic resistance in Aeromonas associated with RTE seafood in Norway.
PubMed ID
33025711 View in PubMed
Less detail

Ampicillin in the treatment of imprisoned patients with gonorrhoea.

https://arctichealth.org/en/permalink/ahliterature254594
Source
Br J Vener Dis. 1973 Jun;49(3):271-3
Publication Type
Article
Date
Jun-1973
Author
T. Jersild
T L Svendsen
Source
Br J Vener Dis. 1973 Jun;49(3):271-3
Date
Jun-1973
Language
English
Publication Type
Article
Keywords
Administration, Oral
Ampicillin - administration & dosage - therapeutic use
Denmark
Female
Gonorrhea - drug therapy
Humans
Male
Penicillin G - therapeutic use
Prisoners
Prisons
Notes
Cites: Br J Vener Dis. 1969 Jun;45(2):144-85787685
Cites: Br J Vener Dis. 1963 Dec;39:225-714086506
Cites: Ugeskr Laeger. 1971 Jul 2;133(26):1253-64998020
Cites: Br J Vener Dis. 1969 Sep;45(3):235-75346421
PubMed ID
4719161 View in PubMed
Less detail

Ampicillin-resistant enterococci in a Swedish university hospital: nosocomial spread and risk factors for infection.

https://arctichealth.org/en/permalink/ahliterature195013
Source
Scand J Infect Dis. 2001;33(3):182-7
Publication Type
Article
Date
2001
Author
E. Torell
O. Cars
A. Hambraeus
Author Affiliation
Department of Medical Sciences, Uppsala University Hospital, Sweden.
Source
Scand J Infect Dis. 2001;33(3):182-7
Date
2001
Language
English
Publication Type
Article
Keywords
Ampicillin Resistance
Anti-Bacterial Agents - therapeutic use
Carrier State - epidemiology - microbiology - transmission
Case-Control Studies
Cross Infection - epidemiology - microbiology - transmission
Drug Resistance, Microbial
Electrophoresis, Gel, Pulsed-Field
Enterococcus - classification - drug effects - isolation & purification
Feces - microbiology
Female
Gram-Positive Bacterial Infections - epidemiology - microbiology - transmission
Humans
Incidence
Infection Control
Longevity
Male
Odds Ratio
Risk factors
Sweden - epidemiology
Time Factors
Abstract
Ampicillin-resistant enterococci (ARE) have recently emerged as clinical pathogens in Sweden. Between 1991 and 1995 the incidence of ARE among enterococcal isolates at Uppsala University Hospital increased from 0.5% to 8.1%. Shedding of ARE from infected cases and risk factors for infection with ARE were studied during a period of 7 months for 38 ARE cases and 38 controls with ampicillin-susceptible enterococci. ARE cases had longer mean duration of hospitalization than controls (29 d vs. 15 d; p = 0.002). In univariate analysis other risk factors for infection with ARE were found to be prior therapy with > 2 antimicrobials (odds ratio [OR] 3.3; 95% confidence interval [CI] 1.2-9.5), > 4 weeks of antimicrobial therapy (OR 6.9; CI 1.8-28.3) and cephalosporin therapy (OR 9.1; CI 2.6-33.7). Fourteen of 26 skin carriers of ARE were found to be shedding ARE to the environment, compared to 2 of 12 non-skin carriers (p = 0.03). Pulsed-field gel electrophoresis suggested multifocal origin of the majority of the infecting ARE strains. Non-recognized fecal colonization and silent spread of ARE among many patients and over a prolonged time period is suggested to be the main explanation for the increase of ARE infections in our hospital. Infection control measures focusing on protecting patients at high risk for ARE infections and further efforts to optimize antimicrobial use are proposed.
PubMed ID
11303807 View in PubMed
Less detail

Ampicillin-resistant Haemophilus influenzae.

https://arctichealth.org/en/permalink/ahliterature27
Source
Communicable Disease Bulletin 2, for week ending February 13, 1976.
Pages 16-17 in Communicable Disease Bulletins 1975-1981.
Publication Type
Article
Date
1982
Author
State of Alaska. Department of Health and Social Sciences. Epidemiology Office.
Source
Communicable Disease Bulletin 2, for week ending February 13, 1976.
Pages 16-17 in Communicable Disease Bulletins 1975-1981.
Date
1982
Language
English
Geographic Location
U.S.
Publication Type
Article
Physical Holding
Alaska Medical Library
Keywords
Kotzebue
Meningitis
Antibiotic sensitivity
Ampicillin
Invasive Hib disease
Notes
From: Fortuine, Robert et al. 1993. The Health of the Inuit of North America: A Bibliography from the Earliest Times through 1990. University of Alaska Anchorage. Citation number 1801.
Less detail

[Ampicillin resistant Haemophilus influenzae. 3 documented cases in Denmark]

https://arctichealth.org/en/permalink/ahliterature41990
Source
Ugeskr Laeger. 1977 Apr 11;139(15):887-9
Publication Type
Article
Date
Apr-11-1977

[Ampicillin-resistant Haemophilus influenzae. Prevalence in isolates from Danish children]

https://arctichealth.org/en/permalink/ahliterature35727
Source
Ugeskr Laeger. 1994 Jul 11;156(28):4141-4
Publication Type
Article
Date
Jul-11-1994
Author
T. Ejlertsen
R B Dessau
T. Højbjerg
Author Affiliation
Klinisk mikrobiologisk afdeling, Aalborg Sygehus.
Source
Ugeskr Laeger. 1994 Jul 11;156(28):4141-4
Date
Jul-11-1994
Language
Danish
Geographic Location
Denmark
Publication Type
Article
Keywords
Adolescent
Ampicillin Resistance
Child
Child, Preschool
Denmark
English Abstract
Haemophilus influenzae - drug effects - immunology - isolation & purification
Humans
Infant
Abstract
The prevalence of ampicillin-resistance was assessed among a total of 2766 strains of H. influenzae isolated from lower respiratory tract secretions, middle ear secretions, spinal fluid specimens, and blood cultures from children 0-15 years of age tested in two separate counties in Denmark during the period from 1986 to May, 1993. All strains were tested for susceptibility to ampicillin with disc or tablet diffusion technique and strains were examined for beta-lactamase production with a chromogenic cephalosporinase test. In the county of Northern Jutland the rate of beta-lactamase production in non-encapsulated H. influenzae was 2.5% in 1986 rising to 9.3% in 1993. The rate of beta-lactamase production in H. influenzae type b was 4.1% without any rise. In the county of Copenhagen the rate of beta-lactamase production in non-encapsulated H. influenzae rose from 6.3% in 1986 to 10.6% in 1992. In 1993 a further increase to 20.7% was noticed. This year the number of specimens sent to the laboratory and the number of H. influenzae isolated were lower compared to previous years. Thus a different selection of patients may explain the increase in the rate of beta-lactamase production in 1993. The rate of beta-lactamase production in H. influenzae type b was 8.5%. No strains were resistant to ampicillin in diffusion test other than the beta-lactamase producers.
PubMed ID
8066910 View in PubMed
Less detail

Ampicillin-resistant Hemophilus influenzae in Canada: nationwide survey of hospital laboratories.

https://arctichealth.org/en/permalink/ahliterature247006
Source
Can Med Assoc J. 1979 Jul 21;121(2):198-202
Publication Type
Article
Date
Jul-21-1979
Author
D W Scheifele
Source
Can Med Assoc J. 1979 Jul 21;121(2):198-202
Date
Jul-21-1979
Language
English
Publication Type
Article
Keywords
Ampicillin - therapeutic use
Canada
Chloramphenicol - therapeutic use
Haemophilus influenzae
Humans
Meningitis, Haemophilus - drug therapy
Penicillin resistance
Retrospective Studies
Notes
Cites: Antimicrob Agents Chemother. 1974 Nov;6(5):620-415825316
Cites: JAMA. 1978 Jan 23;239(4):320-322767
Cites: J Clin Microbiol. 1978 Jun;7(6):519-23307559
Cites: J Infect Dis. 1978 Sep;138(3):421-4308974
Cites: J Pediatr. 1978 Jun;92(6):889-92307055
Cites: Antimicrob Agents Chemother. 1978 Jul;14(1):154-6308347
Cites: J Pediatr. 1977 Feb;90(2):320-1299774
Cites: J Pediatr. 1977 Feb;90(2):319-20299773
Cites: JAMA. 1978 Jan 23;239(4):324-7244331
Cites: Pediatrics. 1976 Sep;58(3):382-71085435
Cites: Lancet. 1974 Feb 23;1(7852):3134130492
Cites: Am J Dis Child. 1976 Sep;130(9):965-708980
Cites: J Pediatr. 1972 Aug;81(2):370-75042500
Cites: Pediatrics. 1976 Sep;58(3):388-911085436
Cites: Pediatrics. 1976 Mar;57(3):4171083008
Cites: Can Med Assoc J. 1975 AUG 9;113(3):222, 2271079748
PubMed ID
316354 View in PubMed
Less detail

135 records – page 1 of 14.